Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ampio Pharmaceuticals Inc. logo

Ampio Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

1.84
 
USD
  
-0.03
  
(-1.60%)
Optionable: Yes  Market Cap: 1 M  90-day average vol: 486,161

Previous close: 1.87  Open: 1.88  Bid: 1.84  Ask: 2.03
52 week range    
1.56   
   8.30
Peers   
AERI / 
RIGL / 
JNJ / 
ALIM / 
PFE / 
REGN / 
Last updated: Wednesday 28th February 2024
44
MarketXLS Rank
60
Value
46
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AMPE Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-66000.0-71000.0-71000.0
Basic EPS total0.46-1.5-1.35-0.09-1.08
Basic weighted shares outstanding3 M3 M3 M4 M4 M0.09 M12 M199 M15 M
Cost of sales-369309.0
Depreciation-72000.0-368000.0-825000.0-1 M-1 M-1 M-1 M-1 M-1 M-1 M
DepreciationAndAmortization-72000.0-368000.0-825000.0-1 M-1 M-1 M-1 M-1 M-1 M-1 M
Diluted EPS total-9.45-11.4-9.3-11.85-0.12-2.1-1.35-0.1-1.47
Diluted weighted shares outstanding3 M3 M3 M4 M0.09 M12 M205 M15 M
Earnings from equity interest-1 M
EarningsFromEquityInterestNetOfTax-1 M
GainOnSaleOfPPE-123000.0-73000.0
GainOnSaleOfSecurity-516840.0-78038.0-1 M-36 M45 M5 M-543000.04 M6 M
GainsLossOnDisposalOfDiscontinuedOperations-10 M
GeneralAndAdministrativeExpense7 M12 M9 M7 M5 M4 M6 M7 M9 M11 M
Gross operating profit50000.076787.0793153.0
Income before tax-25 M-39 M-24 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
Income taxes-791165.0
Interest income12287.022263.059853.0-2 M-38 M-5000.077000.0556000.04000.0200000.0
MinorityInterests519868.0923357.02 M-927830.0
MiscOtherSpecialCharges4361.05716.059853.023479.03086.0-5012.0-1 M-3 M3 M6 M
Net income from total operations-24 M-38 M-32 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
NetIncomeCommonStockholders-24 M-38 M-32 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
NetIncomeContinuousOperations-24 M-38 M-32 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
NetIncomeDiscontinuousOperations-10 M
NetNonOperatingInterestIncomeExpense12287.022263.059853.0-2 M-38 M-5000.077000.0556000.04000.0200000.0
NetOperatingInterestIncomeExpense22263.0-333760.0
Operating income-24 M-39 M-24 M-17 M-16 M-11 M-19 M-16 M-21 M-20 M
Operating income before depreciation (EBITDA)-24 M-39 M-23 M-18 M-50 M35 M-12 M-15 M-16 M-15 M
OperatingExpense-24 M-39 M-24 M-17 M-16 M-11 M-19 M-16 M-21 M-22 M
Other income net516840.0-5716.0-59853.02 M36 M-45 M-5 M616000.0-3 M-4 M
OtherGandA7 M12 M9 M7 M5 M4 M6 M7 M9 M11 M
OtherImpairmentOfCapitalAssets2 M
OtherOperatingExpenses17 M27 M15 M11 M10 M-11 M-19 M-16 M-21 M-22 M
OtherunderPreferredStockDividend-45 M-5 M-3 M
PreferredStockDividends-45 M-5 M-3 M
RentAndLandingFees7 M-306000.09 M7 M5 M4 M6 M7 M9 M11 M
Research & development expense-17 M-27 M-15 M-11 M7 M13 M9 M12 M9 M
ResearchExpense18 M7 M13 M9 M12 M9 M
Revenue per share-66000.0-71000.0-71000.0-195000.0-232000.0
SalariesAndWages-4 M-8 M-6 M-5 M-504000.0-485000.0-1 M-3 M-953000.0
Selling Gen & administrative expense7 M12 M9 M7 M5 M4 M6 M7 M9 M11 M
SellingAndMarketingExpense12 M15 M
SellingExpense12 M15 M
Total Income available for interest expense (EBIT)-25 M-39 M-24 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
Total common shares outstanding3 M3 M3 M4 M6 M11 M13 M15 M15 M
Total net income-24 M-38 M-32 M-19 M-52 M34 M-14 M-16 M-17 M-16 M
Total ordinary shares832021.0832021.0832021.0832021.0832021.0832021.0832021.0832021.0832021.0832021.0
Total revenues50000.076787.01 M
TotalExpenses-24 M-39 M24 M-17 M-16 M-11 M-19 M-16 M21 M-22 M
TotalRevenue50000.076787.01 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University